Charles Schwab’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$23.6M Buy
748,641
+2,492
+0.3% +$78.5K ﹤0.01% 1580
2025
Q1
$24.4M Sell
746,149
-7,214
-1% -$236K ﹤0.01% 1525
2024
Q4
$27.2M Buy
753,363
+40,968
+6% +$1.48M 0.01% 1517
2024
Q3
$22.2M Buy
712,395
+91,354
+15% +$2.85M ﹤0.01% 1638
2024
Q2
$16.6M Buy
621,041
+28,395
+5% +$760K ﹤0.01% 1787
2024
Q1
$20.2M Buy
592,646
+36,716
+7% +$1.25M ﹤0.01% 1602
2023
Q4
$16.1M Buy
555,930
+24,684
+5% +$714K ﹤0.01% 1718
2023
Q3
$14.6M Sell
531,246
-11,262
-2% -$310K ﹤0.01% 1697
2023
Q2
$16.3M Buy
542,508
+32,702
+6% +$983K ﹤0.01% 1629
2023
Q1
$18.5M Buy
509,806
+2,355
+0.5% +$85.3K 0.01% 1530
2022
Q4
$18.1M Buy
507,451
+39,677
+8% +$1.42M 0.01% 1510
2022
Q3
$15.8M Buy
467,774
+38,323
+9% +$1.3M 0.01% 1546
2022
Q2
$12.4M Buy
429,451
+27,161
+7% +$786K ﹤0.01% 1722
2022
Q1
$13M Buy
402,290
+33,198
+9% +$1.07M ﹤0.01% 1803
2021
Q4
$10.8M Buy
369,092
+7,087
+2% +$207K ﹤0.01% 1963
2021
Q3
$9.66M Sell
362,005
-56,535
-14% -$1.51M ﹤0.01% 2031
2021
Q2
$12.9M Sell
418,540
-32,389
-7% -$997K ﹤0.01% 1868
2021
Q1
$11.8M Buy
450,929
+11,432
+3% +$299K ﹤0.01% 1854
2020
Q4
$11.1M Sell
439,497
-7,217
-2% -$182K ﹤0.01% 1801
2020
Q3
$9.31M Buy
446,714
+103,632
+30% +$2.16M ﹤0.01% 1747
2020
Q2
$8.15M Buy
343,082
+22,938
+7% +$545K ﹤0.01% 1769
2020
Q1
$5.76M Sell
320,144
-85,224
-21% -$1.53M ﹤0.01% 1764
2019
Q4
$9.62M Buy
405,368
+6,320
+2% +$150K 0.01% 1688
2019
Q3
$11M Buy
399,048
+42,324
+12% +$1.16M 0.01% 1544
2019
Q2
$11.8M Buy
356,724
+26,687
+8% +$883K 0.01% 1489
2019
Q1
$11.6M Buy
330,037
+12,349
+4% +$433K 0.01% 1494
2018
Q4
$10.6M Buy
317,688
+6,089
+2% +$202K 0.01% 1424
2018
Q3
$15.7M Buy
311,599
+23,662
+8% +$1.19M 0.01% 1324
2018
Q2
$17.2M Sell
287,937
-28,509
-9% -$1.71M 0.01% 1200
2018
Q1
$14.5M Buy
316,446
+30,443
+11% +$1.39M 0.01% 1228
2017
Q4
$11.4M Buy
286,003
+48,732
+21% +$1.94M 0.01% 1379
2017
Q3
$9.49M Buy
237,271
+34,074
+17% +$1.36M 0.01% 1473
2017
Q2
$8.76M Buy
203,197
+7,918
+4% +$341K 0.01% 1450
2017
Q1
$6.11M Buy
195,279
+10,572
+6% +$331K 0.01% 1637
2016
Q4
$4.66M Sell
184,707
-6,610
-3% -$167K 0.01% 1783
2016
Q3
$4.73M Buy
191,317
+54,294
+40% +$1.34M 0.01% 1690
2016
Q2
$2.79M Buy
137,023
+8,387
+7% +$171K ﹤0.01% 1911
2016
Q1
$1.96M Sell
128,636
-184,455
-59% -$2.81M ﹤0.01% 2054
2015
Q4
$4.21M Sell
313,091
-41,694
-12% -$560K 0.01% 1637
2015
Q3
$4.98M Buy
354,785
+203,999
+135% +$2.86M 0.01% 1475
2015
Q2
$2.56M Buy
150,786
+46,578
+45% +$791K ﹤0.01% 1960
2015
Q1
$1.26M Buy
104,208
+38,539
+59% +$466K ﹤0.01% 2291
2014
Q4
$546K Buy
65,669
+22,669
+53% +$188K ﹤0.01% 2588
2014
Q3
$374K Hold
43,000
﹤0.01% 2695
2014
Q2
$471K Buy
43,000
+11,200
+35% +$123K ﹤0.01% 2648
2014
Q1
$285K Hold
31,800
﹤0.01% 2825
2013
Q4
$240K Hold
31,800
﹤0.01% 2899
2013
Q3
$234K Sell
31,800
-7,909
-20% -$58.2K ﹤0.01% 2860
2013
Q2
$255K Buy
+39,709
New +$255K ﹤0.01% 2793